Novo Nordisk Launches $149 Wegovy Pill, Expanding Access to GLP-1 Weight-Loss Drugs
Novo Nordisk launches Wegovy, the first oral GLP-1 pill approved for weight loss in the U.S., offering an alternative to injectable treatments and expanding access to effective weight management solutions.